Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients

被引：0

作者：

Andrea Sacconi

Paola Muti

Claudio Pulito

Giulia Urbani

Matteo Allegretti

Raul Pellini

Nikolay Mehterov

Uri Ben-David

Sabrina Strano

Paolo Bossi

Giovanni Blandino

机构：

[1] Clinical Trial Center,Department of Biomedical

[2] Biostatistics and Bioinformatics,Translational Oncology Research Unit

[3] IRCCS Regina Elena National Cancer Institute,Department of Medical Biology

[4] Surgical Science and Oral Health,Research Institute

[5] Milan University,Department of Human Molecular Genetics and Biochemistry

[6] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Department of Biomedical Sciences

[7] Maxillo-Facial Surgery and Dental Unit,undefined

[8] IRCCS Regina Elena National Cancer Institute,undefined

[9] Otolaryngology Head and Neck Surgery Unit,undefined

[10] IRCCS Regina Elena National Cancer Institute,undefined

[11] Medical University-Plovdiv,undefined

[12] Medical University-Plovdiv,undefined

[13] Faculty of Medicine,undefined

[14] Tel Aviv University,undefined

[15] SAFU Unit,undefined

[16] IRCCS Regina Elena National Cancer Institute,undefined

[17] Humanitas University,undefined

[18] IRCCS Humanitas Research Hospital,undefined

来源：

Molecular Cancer | / 22卷

关键词：

HNSCC; Immunotherapy; Immune checkpoint inhibitor; p53; PDL1; c-MYC; PI3K;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[21] TP53 mutations are associated with a particular pattern of genomic imbalances in head and neck squamous cell carcinoma
Smeets, Serge J.
Braakhuis, Boudewijn J. M.
Ylstra, Bauke
Leemans, C. Rene
Brakenhoff, Ruud H.
CELLULAR ONCOLOGY, 2007, 29 (02) : 160 - 160
[22] TP53 mutations are associated with a particular pattern of genomic imbalances in head and neck squamous cell carcinoma
Smeets, S.
Braakhuis, B.
Leemans, C. R.
Brakenhoff, R.
ORAL ONCOLOGY, 2007, : 196 - 196
[23] The status of MGMT methylation and TP53 mutations in patients with glioblastoma
Jesionek-Kupnicka, Dorota
Zawlik, Izabela
Jesien-Lewandowicz, Emilia
Szybka, Malgorzata
Kulczycka, Dominika
Kusinska, Renata
Kordek, Radzislaw
VIRCHOWS ARCHIV, 2008, 452 : S153 - S154
[24] The status of MGMT methylation and TP53 mutations in patients with glioblastoma
Jesionek-Kupnicka, Dorota
Zawlik, Izabela
Jesien-Lewandowicz, Emilia
Szybka, Malgorzata
Kulczycka, Dominika
Kusinska, Reneta
Pasz-Walczak, Grazyna
Kordek, Radzislaw
VIRCHOWS ARCHIV, 2007, 451 (02) : 240 - 240
[25] TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
Ralf Erber
Christian Conradt
Nils Homann
Christel Enders
Martin Finckh
Andreas Dietz
Hagen Weidauer
Franz X Bosch
Oncogene, 1998, 16 : 1671 - 1679
[26] Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53
Gao, Fan
Hu, Kai
Zheng, Peihao
Shi, Hui
Ke, Xiaoyan
CANCER MEDICINE, 2023, 12 (09): : 10267 - 10279
[27] TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
Erber, R
Conradt, C
Homann, N
Enders, C
Finckh, M
Dietz, A
Weidauer, H
Bosch, FX
ONCOGENE, 1998, 16 (13) : 1671 - 1679
[28] Identification of genetic signatures associated with TP53 status in patients with bladder cancer
Sanchez-Carbayo, M
Lu, ML
Socci, N
Behrendt, N
Li, WT
Cordon-Cardo, C
JOURNAL OF UROLOGY, 2005, 173 (04): : 209 - 210
[29] Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
Lindenbergh-van der Plas, Marlon
Brakenhoff, Ruud H.
Kuik, Dirk J.
Buijze, Marijke
Bloemena, Elisabeth
Snijders, Peter J. F.
Leemans, C. Rene
Braakhuis, Boudewijn J. M.
CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3733 - 3741
[30] TP53 gene mutations in plasma DNA of cancer patients
Silva, JM
Gonzalez, R
Dominguez, G
Garcia, JM
España, P
Bonilla, F
GENES CHROMOSOMES & CANCER, 1999, 24 (02): : 160 - 161

← 1 2 3 4 5 →